• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG 标记自体骨髓源性干细胞在 2 型糖尿病患者中的分布:探索靶向和静脉给药途径。

Biodistribution of 18F-FDG-Labeled Autologous Bone Marrow-Derived Stem Cells in Patients With Type 2 Diabetes Mellitus: Exploring Targeted and Intravenous Routes of Delivery.

机构信息

From the Departments of *Nuclear Medicine, †Endocrinology, ‡Radiodiagnosis, and §Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh.

出版信息

Clin Nucl Med. 2015 Sep;40(9):697-700. doi: 10.1097/RLU.0000000000000850.

DOI:10.1097/RLU.0000000000000850
PMID:26164170
Abstract

AIM AND OBJECTIVES

The study aims to carry out in vivo tracking of stem cells labeled with positron emission tomography (PET) tracer fluorine 18-fluorodeoxyglucose (F-FDG) and find adequate administration methods for these cells in diabetic patients.

MATERIAL AND METHODS

Bone marrow aspirate was taken from the iliac crest of patients. Bone marrow mononuclear cells were separated and purified using centrifugation. These cells were then labeled with PET tracer F-FDG. The labeled stem cells were given in a total of 21 type 2 diabetes mellitus patients comprising 3 groups of 7 patients each. Cells were infused either in peripheral intravenous route or through the targeted routes into the superior pancreaticoduodenal artery and the splenic artery respectively. Biodistribution and quantification studies were carried out at 30 and 90 minutes of stem cell infusion.

RESULTS

Our results show that targeted approach resulted in homing and retention of stem cells in pancreas as compared with the intravenous route where no discernible homing of stem cells was there. Outside the pancreas, liver and spleen showed intense FDG labeled stem cell accumulation. In the intravenous group, lung fields showed retention of cells in the initial biodistribution study at 30 minutes with significant clearance in the delayed 90 minute image.

CONCLUSIONS

Infusion into the superior pancreaticoduodenal artery should be a preferred route than into the splenic artery as the former method resulted in better homing and retention of labeled stem cells. Homing is least likely to occur when the intravenous route is used.

摘要

目的和目标

本研究旨在对经正电子发射断层扫描(PET)示踪剂氟-18-氟代脱氧葡萄糖(F-FDG)标记的干细胞进行体内示踪,并为糖尿病患者找到这些细胞的合适给药方法。

材料和方法

从患者的髂嵴处采集骨髓抽吸物。使用离心法分离和纯化骨髓单核细胞。然后用 PET 示踪剂 F-FDG 对这些细胞进行标记。将标记的干细胞总共给予 21 名 2 型糖尿病患者,每组 7 名。细胞分别通过外周静脉途径或通过靶向途径注入胰十二指肠上动脉和脾动脉。在干细胞输注后 30 和 90 分钟进行生物分布和定量研究。

结果

我们的结果表明,与静脉途径相比,靶向方法导致干细胞在胰腺中的归巢和保留,而静脉途径中没有明显的干细胞归巢。在胰腺外,肝脏和脾脏显示出强烈的 FDG 标记干细胞积累。在静脉组中,在初始生物分布研究中,肺部在 30 分钟时显示出细胞的保留,在延迟的 90 分钟图像中显著清除。

结论

与注入脾动脉相比,将其注入胰十二指肠上动脉应该是一种更好的途径,因为前者导致标记的干细胞更好的归巢和保留。当使用静脉途径时,归巢最不可能发生。

相似文献

1
Biodistribution of 18F-FDG-Labeled Autologous Bone Marrow-Derived Stem Cells in Patients With Type 2 Diabetes Mellitus: Exploring Targeted and Intravenous Routes of Delivery.18F-FDG 标记自体骨髓源性干细胞在 2 型糖尿病患者中的分布:探索靶向和静脉给药途径。
Clin Nucl Med. 2015 Sep;40(9):697-700. doi: 10.1097/RLU.0000000000000850.
2
Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction.心肌梗死患者冠状动脉内注射18F-FDG标记的外周造血干细胞后的组织分布。
J Nucl Med. 2006 Aug;47(8):1295-301.
3
Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus - defining adequate administration methods.2型糖尿病患者的自体骨髓源性干细胞治疗——确定适当的给药方法
World J Diabetes. 2017 Jul 15;8(7):381-389. doi: 10.4239/wjd.v8.i7.381.
4
18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity.18F-FDG 标记间充质干细胞和多能成体祖细胞用于 PET 成像:对超微结构和分化能力的影响。
J Nucl Med. 2013 Mar;54(3):447-54. doi: 10.2967/jnumed.112.108316. Epub 2013 Jan 25.
5
(18)F-FDG cell labeling may underestimate transplanted cell homing: more accurate, efficient, and stable cell labeling with hexadecyl-4-[(18)F]fluorobenzoate for in vivo tracking of transplanted human progenitor cells by positron emission tomography.(18)F-FDG 细胞标记可能低估移植细胞归巢:使用十六烷基-4-[(18)F]氟苯甲酸进行更准确、高效和稳定的细胞标记,通过正电子发射断层扫描对移植的人祖细胞进行体内追踪。
Cell Transplant. 2012;21(9):1821-35. doi: 10.3727/096368911X637416. Epub 2012 Mar 28.
6
Altered biodistribution of FDG in patients with type-2 diabetes mellitus.2型糖尿病患者中氟代脱氧葡萄糖(FDG)生物分布的改变。
Ann Nucl Med. 2014 Jul;28(6):505-11. doi: 10.1007/s12149-014-0840-y. Epub 2014 Mar 21.
7
Bone marrow mesenchymal stem cell transplantation in acute brain trauma. Improvement of brain glucose metabolism in a rat model.急性脑外伤中的骨髓间充质干细胞移植。大鼠模型中脑葡萄糖代谢的改善。
Nuklearmedizin. 2013;52(5):192-7. doi: 10.3413/Nukmed-0543-12-11. Epub 2013 May 15.
8
Monitoring of bone marrow cell homing into the infarcted human myocardium.监测骨髓细胞归巢至梗死的人类心肌。
Circulation. 2005 May 3;111(17):2198-202. doi: 10.1161/01.CIR.0000163546.27639.AA. Epub 2005 Apr 25.
9
Safety and biodistribution study of bone marrow-derived mesenchymal stromal cells and mononuclear cells and the impact of the administration route in an intact porcine model.骨髓间充质基质细胞和单核细胞的安全性及生物分布研究以及给药途径对完整猪模型的影响。
Cytotherapy. 2015 Apr;17(4):392-402. doi: 10.1016/j.jcyt.2014.12.004. Epub 2015 Jan 15.
10
Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.多发性骨髓瘤患者基线18F-FDG PET/CT检查结果与骨髓中表达CD38和CD138的骨髓瘤细胞及临床参数之间的相关性
Turk J Haematol. 2018 Aug 3;35(3):175-180. doi: 10.4274/tjh.2017.0372. Epub 2018 May 28.

引用本文的文献

1
Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities.间充质干细胞在人类疾病再生治疗中的转化潜力:挑战与机遇。
Stem Cell Res Ther. 2024 Aug 26;15(1):266. doi: 10.1186/s13287-024-03885-z.
2
Standardisation is the key to the sustained, rapid and healthy development of stem cell-based therapy.标准化是干细胞治疗持续、快速和健康发展的关键。
Clin Transl Med. 2024 Apr;14(4):e1646. doi: 10.1002/ctm2.1646.
3
Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes.
间充质干细胞(MSCs):2型糖尿病的一种新型疗法。
Stem Cells Int. 2022 Aug 22;2022:8637493. doi: 10.1155/2022/8637493. eCollection 2022.
4
Stem cell-based therapy for human diseases.基于干细胞的人类疾病治疗方法。
Signal Transduct Target Ther. 2022 Aug 6;7(1):272. doi: 10.1038/s41392-022-01134-4.
5
Biodistribution studies for cell therapy products: Current status and issues.细胞治疗产品的生物分布研究:现状与问题
Regen Ther. 2021 Jul 12;18:202-216. doi: 10.1016/j.reth.2021.06.005. eCollection 2021 Dec.
6
Biodistribution of Mesenchymal Stromal Cells after Administration in Animal Models and Humans: A Systematic Review.间充质基质细胞在动物模型和人类体内给药后的生物分布:一项系统评价。
J Clin Med. 2021 Jun 29;10(13):2925. doi: 10.3390/jcm10132925.
7
A systematic review and meta-analysis of cell-based interventions in experimental diabetic kidney disease.基于细胞的干预措施在实验性糖尿病肾病中的系统评价和荟萃分析。
Stem Cells Transl Med. 2021 Sep;10(9):1304-1319. doi: 10.1002/sctm.19-0419. Epub 2021 Jun 9.
8
Mesenchymal Stem Cell-Based Therapy for Diabetes Mellitus: Enhancement Strategies and Future Perspectives.基于间充质干细胞的糖尿病治疗:增强策略和未来展望。
Stem Cell Rev Rep. 2021 Oct;17(5):1552-1569. doi: 10.1007/s12015-021-10139-5. Epub 2021 Mar 5.
9
Effects and mechanism of stem cells from human exfoliated deciduous teeth combined with hyperbaric oxygen therapy in type 2 diabetic rats.人脱落乳牙干细胞联合高压氧疗法对 2 型糖尿病大鼠的作用及机制。
Clinics (Sao Paulo). 2020 Jun 3;75:e1656. doi: 10.6061/clinics/2020/e1656. eCollection 2020.
10
Identifying the Therapeutic Significance of Mesenchymal Stem Cells.鉴定间充质干细胞的治疗意义。
Cells. 2020 May 6;9(5):1145. doi: 10.3390/cells9051145.